Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BD BBL™ Sensi-Disc™ Lefamulin 20µg (LMU-20)

K-Number: K230651 · 2023-06-07

Decision Date2023-06-07
Product CodeJTN
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

BD BBL™ Sensi-Disc™ Lefamulin 20µg (LMU-20) is a medical device manufactured by Becton, Dickinson and Company. It received FDA 510(k) clearance on 2023-06-07 under approval number K230651. The device is classified under product code JTN. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BD BBL™ Sensi-Disc™ Lefamulin 20µg (LMU-20)?

BD BBL™ Sensi-Disc™ Lefamulin 20µg (LMU-20) is a medical device that received FDA 510(k) clearance on 2023-06-07. It is manufactured by Becton, Dickinson and Company. The 510(k) number is K230651.

When was BD BBL™ Sensi-Disc™ Lefamulin 20µg (LMU-20) approved by the FDA?

BD BBL™ Sensi-Disc™ Lefamulin 20µg (LMU-20) received FDA 510(k) clearance on 2023-06-07, under approval number K230651.

What company makes BD BBL™ Sensi-Disc™ Lefamulin 20µg (LMU-20)?

BD BBL™ Sensi-Disc™ Lefamulin 20µg (LMU-20) is manufactured by Becton, Dickinson and Company.

What is the FDA product code for BD BBL™ Sensi-Disc™ Lefamulin 20µg (LMU-20)?

The FDA product code for BD BBL™ Sensi-Disc™ Lefamulin 20µg (LMU-20) is JTN.

Related PubMed Literature

Other Devices by Becton, Dickinson and Company

View all 100 devices →

Related Devices (Code: JTN)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.